(Q80459766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Manfred Windisch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Birgit Hutter-Paier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Edith Schreiner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Robert Wronski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Neuroscience

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

155-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15314265%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/jmn:24:1:155

31 December 2019

exact match

0 references

cites work

General aspects of neurodegeneration.

1 reference

12 December 2020

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

1 reference

12 December 2020

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

12 December 2020

Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease

1 reference

12 December 2020

Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

1 reference

12 December 2020

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

1 reference

12 December 2020

Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma

1 reference

12 December 2020

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

1 reference

12 December 2020

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

1 reference

12 December 2020

Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease.

1 reference

12 December 2020

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

1 reference

12 December 2020

Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

1 reference

12 December 2020

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs

1 reference

12 December 2020

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease

1 reference

12 December 2020

alpha-Synuclein affects the MAPK pathway and accelerates cell death

1 reference

12 December 2020

Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

Lipid binding inhibits alpha-synuclein fibril formation

1 reference

12 December 2020

Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease

1 reference

12 December 2020

Conformational properties of alpha-synuclein in its free and lipid-associated states

1 reference

12 December 2020

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study

1 reference

12 December 2020

Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease

1 reference

12 December 2020

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

12 December 2020

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

1 reference

12 December 2020

Oxidized glutathione stimulated the amyloid formation of alpha-synuclein

1 reference

12 December 2020

Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway

1 reference

12 December 2020

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

1 reference

12 December 2020

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

12 December 2020

Alpha-synuclein inclusions in Alzheimer and Lewy body diseases

1 reference

12 December 2020

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

12 December 2020

Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125.

1 reference

12 December 2020

The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro

1 reference

12 December 2020

The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases

1 reference

12 December 2020

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells

1 reference

12 December 2020

Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells

1 reference

12 December 2020

Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic

1 reference

12 December 2020

Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein

1 reference

12 December 2020

Parkin and the molecular pathways of Parkinson's disease

1 reference

12 December 2020

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

12 December 2020

Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons

1 reference

12 December 2020

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

1 reference

12 December 2020

Current drugs and future hopes in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseases

1 reference

12 December 2020

"Emerging Alzheimer's disease therapies: focusing on the future".

1 reference

12 December 2020

Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes

1 reference

12 December 2020

Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation

1 reference

12 December 2020

Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease

1 reference

12 December 2020

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells

1 reference

12 December 2020

6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.

1 reference

12 December 2020

Mechanisms of neurodegenerative disorders: Part 1: protein aggregates.

1 reference

12 December 2020

Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein

1 reference

12 December 2020